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. A further potential for damage arises because the cells and molecules of the immune system that respond to pathogen-derived antigens can also respond to self-antigens, and if this reactivity is uncontrolled, it can result in autoimmune disease 2 . Inflammation and the immune response to pathogens are regulated by various host suppressor mechanisms, including the production of antiinflammatory cytokines by cells of the innate immune system in response to conserved pathogen-derived products 3, 4 . However, recent evidence indicates that the adaptive immune system might also help to control infection-induced immunopathology through the generation of antigen-specific regulatory T cells (FIG. 1) .
Therefore, regulatory T cells might have a host-protective role in immunity to infection.
It is also possible that pathogens can exploit regulatory T cells to subvert the protective immune responses of the host. Although the infections caused by many pathogens are self-limiting in immunocompetent hosts, other pathogens can persist and cause CHRONIC INFECTIONS. In infections such as those caused by HIV, hepatitis C virus (HCV) and many parasites, the pathogen persists because the appropriate immune response required for pathogen elimination either fails to develop or is suppressed. Furthermore, there is evidence that the incidence of atopic diseases (such as allergy and asthma) and autoimmune diseases is lower in individuals infected with helminth parasites or exposed to microbial products as children 5, 6 . It seems that many, and possibly all, pathogens that cause PERSISTENT INFECTIONS or chronic infections have evolved strategies to subvert the immune responses of the host. These strategies include evasion of humoral and cellular immunity by ANTIGENIC VARIATION, interference with antigen processing or presentation, and subversion of phagocytosis and killing by cells of the innate immune system 7 . However, of most relevance to this discussion is a common immune-subversion strategy used by many pathogens that involves increasing the production of anti-inflammatory or immunosuppressive Our understanding of the role of regulatory T cells in immune homeostasis is far from complete, and there are several important unanswered questions. How do regulatory mechanisms control the development of autoimmunity but allow the same type of immune response to mediate protection against infection? What is the advantage to the host of inducing microorganism-activated regulatory T cells that suppress the immune responses that facilitate pathogen elimination? However, our knowledge has increased in the past few years, and several studies, mainly in mouse models of responses, which normally function to control or terminate the protective effector immune responses of the host. This can be achieved in the following ways: through the production of molecules with homology to human cytokines, such as viral interleukin-10 (IL-10); through the direct induction of host immunosuppressive cytokines, such as IL-10 and transforming growth factor-β (TGF-β), which are produced by innate immune cells in response to pathogen-derived molecules 3, 8 ; or indirectly through the generation of regulatory T cells.
PERSISTENT INFECTIONS
Non-lethal infections (such as infection with Bordetella pertussis) that are not cleared immediately (lasting for weeks or months rather than days) and are usually associated with the delayed development or suppression of anti-pathogen immune responses. In persistent viral infections, virus production occurs in a cell that is not killed by the virus (non-lytic); this includes chronic, latent and transforming infections. ANTIGENIC VARIATION Changes in the composition, structure or amino-acid sequence of antigenic components of pathogens recognized by T or B cells, which allow the microorganism to escape recognition by the adaptive immune response. , together with various protein components of the complement system, provide the first line of defence against invading microorganisms. Binding of conserved pathogen-derived molecules to pattern-recognition receptors (PRRs), such as Toll-like receptors (TLRs), on the cell surface of macrophages and DCs activates the production of pro-inflammatory cytokines and chemokines, which help to attract other effector cells to the site of infection. Pathogenactivated DCs present pathogen-derived antigens to T cells and promote the differentiation of naive T cells to various subtypes of effector CD4 + and CD8 + T cell. CD4 + T helper 1 (T H 1) cells secrete interferon-γ (IFN-γ), which activates the anti-microbial activity of macrophages and helps B-cell production of IgG2a antibodies, whereas T H 2 cells provide help for B-cell production of IgG1, IgA and IgE. CD8 + T cells lyse host cells infected with viruses, intracellular bacteria or parasites. Many of these responses can cause host tissue damage -for example, excessive inflammation from uncontrolled pro-inflammatory cytokine and chemokine production by innate immune cells and T H 1 cells, eosinophilia and allergic reactions from uncontrolled T H 2-cell responses, and killing of host cells by CD8 + cytotoxic T lymphocytes (CTLs) and NK cells. In normal individuals, regulatory T cells (both natural regulatory T cells circulating in the periphery and those induced by infection) help to control these effector functions and the associated damage to host tissues. IL, interleukin; TCR, T-cell receptor; TNF, tumour-necrosis factor. the cells being studied in different laboratories. It seems that natural self-antigen-reactive CD4 + CD25
+ T Reg cells develop in the thymus and then enter peripheral tissues, where they suppress the activation of other self-reactive T cells 9, 10 . By contrast, IL-10-or TGF-β-secreting regulatory T cells, which are known as T regulatory 1 (T R 1) or T helper 3 (T H 3) cells respectively, are generated from naive T cells in the periphery after encounter with antigen presented by dendritic cells (DCs) that have an activation status distinct from those DCs that promote the differentiation of T H 1 or T H 2 cells. In addition to these well-defined populations of CD4 + regulatory T cells, there is also evidence for an immunosuppressive function of CD8 + regulatory T cells that secrete either IL-10 or TGF-β 11, 12 . Furthermore, antigen-activated CD8 + γδ T cells can prevent insulin-dependent diabetes in mice 13 , and IL-10-and TGF-β-producing regulatory γδ T cells can suppress the anti-tumour activity of CTLs and NK cells 14 . In addition, natural killer T (NKT) cells, which co-express NK-cell and T-cell markers, can secrete regulatory cytokines, including IL-10 (REF. 15 16 , who showed that the transfer into ATHYMIC NUDE mice of lymphoid-cell populations from which CD4 + T cells expressing the α-chain of the IL-2 receptor (IL-2Rα; also known as CD25) had been removed caused spontaneous development of various T-cell-mediated autoimmune diseases. Furthermore, reconstitution with CD4 + CD25 + T cells prevented the development of autoimmunity. This discovery, together with the work of Powrie and colleagues on a CD45RB low population of T cells 17 , challenged traditional theories about clonal deletion being the only mechanism of self-tolerance and provided convincing evidence that self-antigen-reactive T cells that cause autoimmune diseases can be controlled through active suppression by natural T Reg cells. CD4 +
CD25
+ T Reg cells, which constitute 5-10% of peripheral T cells in mice, are continuously produced in the thymus as a functionally mature T-cell population that includes cells with immunosuppressive activity. However, CD25 is not a definitive marker of natural regulatory T cells; CD25 is an activation marker for T cells and is therefore also expressed by effector T H 1 and T H 2 cells, and suppressive function has also been documented for CD25 -T cells. These observations led to attempts to find alternative markers for regulatory T cells. Putative markers for regulatory T cells include cell-surface expression of CD38, CD62L, CD103 or glucocorticoid-induced tumournecrosis factor (TNF) receptor (GITR), or low levels of cell-surface CD45RB expression or intracellular expression of the transcriptional repressor FOXP3 (forkhead box P3) [17] [18] [19] . FOXP3 seems to be the most promising marker of natural regulatory T cells, and recent studies have shown that transfection of CD4 + CD25 -T cells infection with bacteria, viruses, parasites or fungi, have shown that regulatory T cells specific for pathogenderived antigens are induced during infection. Furthermore, studies involving depletion or transfer of CD4 + CD25 + regulatory T cells (T Reg cells) have provided evidence that natural T Reg cells can influence the immune response to pathogens and the outcome of infectious disease. This article reviews the recent evidence for pathogen-specific regulatory T cells and their role in infection, focusing on the protective role of these cells in immunity to pathogens, as a means of limiting infection-induced immunopathology, as well as the exploitation of regulatory T cells by pathogens, as an immune-subversion mechanism to prolong pathogen survival in the host.
The biology of regulatory T cells
Natural and inducible regulatory T cells. It is now firmly established that there are both natural (or constitutive) and inducible (or adaptive) populations of regulatory T cells (FIG. 2) , which probably have complementary and overlapping functions in the control of immune responses. However, the lineage relationship, if any, between these subtypes remains to be defined. The failure to identify definitive cell-surface markers for either population has compromised advances in the field and has led to some confusion about the precise nature of ATHYMIC Mice that lack a thymus and are therefore deficient in T cells.
NUDE
A mutation in mice that causes both hairlessness and defective formation of the thymus, which results in a lack of mature T cells. 37 . Therefore, the targets of suppressor activity by regulatory T cells are immune responses that confer protection against infection with microorganisms and also responses that can cause collateral damage to host tissue during infection.
Mechanisms of suppression.
The mechanism of the suppressive function of natural and inducible regulatory T cells is still debated, but in different model systems, suppressive activity has been shown to be mediated either through secretion of immunosuppressive cytokines or through cell-cell contact (FIG. 3) . Many studies have shown that the suppression mediated by T R 1 or T H 3 cells can be reversed using antibodies specific for IL-10 or TGF-β. IL-10 inhibits the production of TNF and IL-12 by DCs and macrophages, whereas TGF-β inhibits T H 1-cell responses through its effects on expression of the transcription factor T-bet and the IL-12R [38] [39] [40] . It has been reported that the production of TGF-β by regulatory T cells induces IL-10 production by T H 1 cells through SMAD4-induced activation of the IL-10 promoter 41 . This indicates that there might be interdependent, as well as distinct, roles for IL-10 and TGF-β in the immunosuppressive function of inducible regulatory T cells. Cytokine-mediated suppression might also operate at the level of the antigen-presenting cell, because IL-10 and regulatory T cells can inhibit the expression of MHC class II and co-stimulatory molecules by DCs 40, 42 . The suppressive mechanisms of CD4 + CD25
+ T Reg cells are not clear, but there is evidence that cell-cell contact is required and that expression of the inhibitory costimulatory molecule CTLA4 (CTL antigen 4) might be involved 43 . However there is also conflicting evidence concerning roles for IL-10 and secreted or cell-surface TGF-β 29, 43, 44 . Finally, it has also been proposed that regulatory T cells might inhibit pathogenic effector T-cell responses by competing for shared resources in the normal immune system 45 . So, although the mechanisms of suppression by T R 1 and T H 3 cells seem to be mediated mainly by cytokines, CD4 + CD25 + T Reg cells might use many and as-yet-unidentified mechanisms to mediate suppression.
Pathogen-specific regulatory T cells
Studies involving cell depletion and transfer, as well as cytokine-knockout or -inhibition experiments, have provided considerable indirect evidence of a role for inducible (TABLE 1) and natural (TABLE 2) regulatory T cells during infection. However, there are still only a small number of reports showing that regulatory T cells are specific for pathogen-derived antigens.
with Foxp3 confers them with intracellular regulatory activity 20 . T-cell receptor (TCR) engagement seems to be necessary for optimal suppressive activity, and it has been assumed that circulating CD4 + CD25
+ T Reg cells are activated by the recognition of self-antigens in vivo 9 . However, evidence that natural regulatory T cells are antigen specific is still limited.
A unique cytokine-production profile, rather than the expression of cell-surface markers, has been used to define at least two populations of inducible regulatory T cells. Although it had been recognized for some time that T cells with suppressive or ANERGIC activity could be generated in vivo in certain situations -for example, in oral tolerance 21, 22 or during infection with certain pathogens, such as rabies virus 23 , Brugia malayi 24 and Mycobacterium tuberculosis 25 -it was not until the mid-1990s that these cells were given a unified nomenclature. Weiner and colleagues showed that the induction of oral tolerance and the prevention of T H 1-cell-mediated autoimmune diseases by feeding self-antigens were associated with the generation of TGF-β-secreting T cells in the gut 26 . These T cells, which were distinct from T H 2 cells in that they produced large amounts of TGF-β and varying amounts of IL-4 and IL-10, were named T H 3 cells. In 1997, Groux et al. showed that repeated in vitro stimulation of T cells isolated from ovalbumin-specific TCR-transgenic mice with their cognate antigen in the presence of IL-10 resulted in the expansion of a population of regulatory T cells that produced large amounts of IL-10 and could suppress T H 1-cell responses and T H 1-cell-mediated autoimmune diseases 27 ; they called these cells T R 1 cells. More recently, it has been shown that antigen-specific T R 1 cells can be generated in vivo during certain infections and that IL-10 might be a differentiation factor rather than a growth factor for these cells 28 . Because T H 2 cells secrete the immunosuppressive or antiinflammatory cytokines IL-10 and IL-4, these cells might also have regulatory function, as well as effector function, but they are distinguished from T H 3 and T R 1 cells by the production of large amounts of IL-4 and smaller amounts of IL-10, as well as a lack of TGF-β production.
Targets of suppressor activity. Immunity to intracellular pathogens is mediated by CD4
+ T H 1 cells and CD8 + CTLs, whereas immunity to extracellular pathogens is mediated by antibodies and T H 2 cells. Innate immune responses also have a protective role early in infection and instruct the adaptive immune response (FIG. 1) . Each of these effector mechanisms can be suppressed by natural and inducible regulatory T cells. It has been shown that T R 1 cells and CD4 + CD25 + T Reg cells can suppress the proliferation of and cytokine production by naive CD4 + CD25 -T cells or antigen-specific T H 1 or T H 2 cells in vitro [28] [29] [30] [31] [32] [33] . There is more-limited evidence that regulatory T cells can suppress pathogen-specific T cells in vivo; existing evidence includes T R 1-cell-mediated suppression of interferon-γ (IFN-γ) production by T H 1 cells in response to Bordetella pertussis 28 humans infected with HCV 46 or the nematode parasite Onchocerca volvulus 47, 48 . The study involving B. pertussis 28 showed direct evidence of suppression of T H 1 cells by T R 1-cell clones specific for bacterial antigens, and the human studies [46] [47] [48] showed indirect evidence of a role for T R 1 cells through increased IFN-γ production in the presence of IL-10-specific antibodies. The studies with B. pertussis 28 and of virus-specific CD8 + regulatory T cells in chronic HCV infection 49 indicate that antigen-specific regulatory T cells are recruited to the site of infection in mucosal tissues. More recently, antigen-specific T R 1 cells have been described in several other chronic infections, including infection with Epstein-Barr virus (EBV) 50 , M. tuberculosis 25, 51, 52 , HIV 53 and murine leukaemia virus, which is a mouse model of AIDS 54 . It has also been shown that IL-10-producing regulatory T cells can be induced in vitro by DCs stimulated with phosphatidylserine isolated from Schistosoma mansoni 55 . Although the problems of cultivating and cloning antigen-specific regulatory T cells in vitro have hampered advances in this area, it is tempting to speculate T R 1 cells and T H 3 cells. Although many studies have shown that pathogens, in particular those that cause chronic infections or are associated with immunosuppression, induce production of the regulatory cytokines IL-10 and TGF-β, the cellular source of these cytokines has not always been defined. In some cases, it has been shown that innate immune cells, usually macrophages or more rarely DCs, are the source, whereas in other studies, it has been shown that these cytokines are produced by T cells 8 . However, the distinction between IL-10 or TGF-β production by T H 2 cells versus regulatory T cells has not always been made. The definitive demonstration of antigen-specific regulatory T cells depends on the generation of antigen-specific T-cell clones or on careful ex vivo intracellular cytokine staining of antigen-stimulated T cells, showing high levels of IL-10 production, no IL-4 production and low (human) or no (mouse) IFN-γ production.
The first definitive observations of inducible antigenspecific T R 1-cell clones generated during infection were made using mice infected with B. pertussis 28 and www.nature.com/reviews/immunol R E V I E W S T cells from IL-10-deficient mice and produce IL-10 after exposure to H. hepaticus-derived antigens in vitro indicate that these regulatory T cells, rather than being endogenous, might be a memory population resulting from previous exposure to bacterial antigens.
Protective role of regulatory T cells in infection
There is convincing evidence of a protective role for regulatory T cells against autoimmune diseases, allograft rejection and allergy, in these situations, they suppress potentially pathogenic immune responses mediated by effector T H 1 cells, T H 2 cells or CTLs 2, 16, 27, [57] [58] [59] . As these effector T-cell responses also have important roles in protection against pathogens, it might seem counterintuitive that regulatory T cells could have a protective role in infection. However, in many infectious diseases, immune responses to the pathogen can result in collateral damage to host tissues, and immunoregulatory mechanisms, including the induction of regulatory T cells, are essential to control this immunopathology. + T cells, which are not induced in CD86-or CD28-deficient mice or in situations in which IL-10-mediated signalling is deficient, the fungal growth is reduced, but inflammatory pathology is increased 70 . Furthermore, transfer of IL-10-and TGF-β-secreting CD4 + CD25
+ T cells decreased inflammation in CD86-deficient mice. In a separate study, an absence of TLR2 was associated with impaired IL-10 production, fewer CD4 + CD25
+ T Reg cells and more inflammatory infiltrate, but lower pathogen load in C. albicans-infected mice 71 . So, although regulatory T cells might compromise fungal clearance, they can also be beneficial to the host by limiting infection-induced pathology.
Parasites. In human malaria, polymorphisms in the TNF promoter have been associated with disease severity; among children with severe malaria, those with the TNF-308A allele had lower plasma levels of IL-10 than of TNF 72 . Furthermore, higher ratios of IL-10 to TNF in children with mild malaria compared with those who have severe malaria indicate a role for IL-10 in controlling the excessive inflammatory activities of TNF 73 . Although these studies do not provide direct evidence that IL-10 is produced by parasite-specific regulatory T cells, it has been suggested that regulatory T cells might contribute to the anti-inflammatory cytokine pool that controls TNF-mediated inflammation in malaria 1 . These observations are complemented by studies in mice showing that infection with Plasmodium chabaudi chabaudi is more severe in IL-10-deficient mice than in wild-type mice and that this is associated with increased inflammation, including increased production of TNF, IFN-γ and IL-12 (REF. 74 ). Treatment of these infected, IL-10-deficient mice with TNF-specific antibodies increases survival 74 . Furthermore, treatment of infected mice with a neutralizing antibody specific for TGF-β exacerbated infection with Plasmodium berghei and P. chabaudi chabaudi, and treatment with recombinant lesions by preventing the induction of pathogenic CD4 + T cells and by limiting the migration of these cells to inflammatory sites. Therefore, in chronic viral infections, regulatory T cells might be beneficial to the host by maintaining a balance between efficient effectors and memory responses, but with a low level of inflammation that causes minimal damage to the host.
Bacteria. Indirect evidence of a protective role for IL-10-producing regulatory T cells in host defence against bacteria-induced immune-mediated pathology has come from studies showing that disease severity is increased in IL-10-deficient mice. IL-10-deficient mice succumb more readily to primary and SECONDARY INFECTION with L. monocytogenes than control mice; the IL-10-deficient mice have an increased number of cells in the inflammatory infiltrate, increased production of pro-inflammatory cytokines in the brain and increased severity of brain lesions 63 . Peritonitis and mortality from infection with Escherichia coli is increased in IL-10-deficient mice, despite accelerated clearance of the bacteria compared with wild-type animals 64 . Colonization of the gastric mucosa by Helicobacter pylori is reduced in IL-10-deficient mice, but the severity of chronic active gastritis is significantly greater than in wild-type mice 65 . Similarly, IL-10-deficient mice infected with H. hepaticus develop severe inflammation that is associated with IL-12 production and T H 1-cell responses 66 . The IL-10 that helps to limit inflammation during bacterial infection might, in part, be derived from innate immune cells. However, it has been shown that the induction of IL-10 production by macrophages and DCs in response to certain pathogen-derived molecules facilitates the induction of T R 1 cells, thereby amplifying the effect of IL-10 produced by innate immune cells 28 . Indeed, studies with mice that lack functional TOLL-LIKE RECEPTOR 4 (TLR4-defective mice) have indicated that IL-10 produced by both innate immune cells and T R 1 cells might help to limit inflammatory pathology in the lungs induced by B. pertussis infection. B. pertussis stimulates IL-10 production by DCs and macrophages and generates T R 1 cells in the respiratory tract of infected mice. However, TLR4-defective mice have reduced IL-10 production by DCs and macrophages and do not generate T R 1 cells when infected with B. pertussis 67 . These mice have significantly greater cellular infiltrates, lung damage and bacterial loads than wild-type mice, which has led to the hypothesis that the induction of T R 1 cells helps to limit inflammatory pathology and thereby improves pathogen elimination by preventing damage to the ciliated epithelial cells required for removal of the bacteria from the lungs.
Direct evidence of a role for CD4 + CD25 + T Reg cells in the prevention of intestinal inflammation has come from the demonstration that infection with H. hepaticus induces a population of CD4 + CD45RB low regulatory T cells that inhibit the development of colitis in IL-10-deficient mice 56 . Removal of CD25 + T cells from the lymph-node cells used to reconstitute athymic mice before infection with H. pylori reduced the bacterial load but increased the severity of gastritis 68 . 31 . Furthermore, ablation of IL-10-secreting regulatory T cells in mice prevented the progression of mouse AIDS (an immunodeficiency syndrome induced by murine leukaemia virus) 54 . Persistent infection of mice with the Friend retrovirus is associated with a decreased ability to develop anti-tumour immune responses 83 . IL-10-producing CD4 + T cells from mice persistently infected with Friend virus suppress IFN-γ production by CD8 + T cells 84 . Similarly, in humans infected with EBV, T R 1 cells are induced that are specific for LMP1 (latent membrane protein 1) of EBV, and these cells inhibit T H 1-cell responses to other EBV proteins, which might facilitate viral persistence and promote the induction of EBV-associated tumours 50 .
TGF-β slowed the rate of parasite growth and increased survival 75 . CD4 + CD25 + T cells and CD8 + T cells from malaria-infected mice secreted high levels of TGF-β in response to parasite-derived antigens in vitro 76 , which indicates that antigen-specific CD8 + regulatory T cells might help to control malaria-induced inflammation.
IL-10-producing CD4 + CD25 + T cells are induced in mice during infection with S. mansoni, and these regulatory T cells (as well as the production of IL-10 by innate immune cells) help to protect the host from the hepatocyte damage induced by S. mansoni eggs and to prevent death from the infection through immune-mediated pathology 77 . Similarly, depletion of CD4 + CD25
+ T cells increased the parasite load, severity of colon lesions and colitis in L. major-infected SEVERE COMBINED IMMUNODEFICIENT (SCID) mice adoptively transferred with splenocytes 78 . Although infection of IL-10-deficient mice with L. major is associated with increased parasite-specific immune responses and pathogen clearance from the host, this sterilizing cure results in a loss of immune memory and therefore of resistance to re-infection by the same parasite 29 . Therefore, regulatory T cells seem to control the immune response sufficiently to contain but not eradicate the infection, thereby suppressing potentially pathogenic T-cell effector responses but allowing the maintenance of T-cell memory.
Pathogen immune evasion
Although regulatory T cells are beneficial to the host by preventing immunopathology and enabling the development of immune memory, they can also be beneficial to the pathogen, enabling it to establish a chronic infection. Many pathogens have evolved strategies that facilitate their persistence, largely through their ability to evade or subvert the host immune response. One strategy is to induce a state of immunosuppression, either through direct interference with host immune effector mechanisms or through the production of immunosuppressive cytokines. Many viruses produce antagonists of pro-inflammatory cytokines or their receptors, or molecules that are homologous to host IL-10 or TGF-β, or they stimulate the production of anti-inflammatory cytokines by host macrophages or other innate immune cells 3, 8 . It has recently been recognized that parasite-induced immunosuppression can also be extended to the induction of T cells with suppressor activity, including natural and inducible regulatory T cells.
Viruses. Most patients infected with HCV remain persistently infected despite the induction of HCV-specific antibodies and T-cell responses. Many chronically infected patients remain disease free for decades; others go on to develop cirrhosis of the liver and, in certain cases, hepatocarcinoma. It has recently been shown that patients with chronic HCV infection have circulating HCV-specific CD4 + T R 1 cells 46 and CD8 + regulatory T cells 49 . These regulatory T cells seem to be capable of inhibiting anti-viral immunity, because the addition of a neutralizing IL-10-specific antibody significantly increased HCV-specific IFN-γ production by T cells www.nature.com/reviews/immunol R E V I E W S and that this might be a strategy used by the bacteria to evade host immune responses. Indirect evidence of a suppressive role for CD4 + regulatory T cells in the development of memory CD8 + T cells has also been provided by studies using mice infected with L. monocytogenes, in which removal of CD4 + T cells increases the generation of CD8 + T-cell responses and increases protection against infection induced by immunization with killed L. monocytogenes 90 .
Parasites. Infection with malaria parasites is persistent and is associated with suppressed immune responses both to the parasite and to unrelated antigens. In a mouse model of malaria, depletion of CD4 + CD25 + T Reg cells protected mice against lethal infection with Plasmodium yoelii 91 and reduced the parasite load in naive and immunized mice infected with P. berghei 92 . CD25
+ T-cell depletion also reversed the defect in the proliferative response of splenocytes from P. yoelii-infected mice to parasitized erythrocytes 91 . Furthermore, treatment of P. yoelii-infected mice with antibodies specific for TGF-β and IL-10 reduced parasitaemia and increased survival 76 . Similarly, infection of IL-10-deficient mice with L. major results in more rapid clearance of the infection 93 . Although susceptibility to L. major infection in BALB/c mice has been associated with IL-4 production and T H 2-cell polarization, recent evidence indicates that IL-10 production by regulatory T cells might have an important role in persistence of L. major infection in these mice 94 . IL-10-deficient mice clear L. major infection more rapidly than wild-type mice. Furthermore, CD4 + CD25 + T Reg cells specific for L. major antigens have been shown to accumulate rapidly at the site of infection in the dermis. These regulatory T cells suppress the ability of effector T cells to eliminate the parasite from the host 29 . Therefore, pathogens have evolved strategies for persistence by the subversion of host-protective immune responses through activation of anti-inflammatory cytokine production by innate immune cells and through activation of natural and inducible regulatory T cells.
Pathogen-activated DCs induce regulatory T cells
During infection, the differentiation of naive T cells to distinct effector CD4 + T-cell subtypes is controlled by DCs and regulatory cytokines produced by innate immune cells (FIG. 4) . Following the binding of conserved pathogen-derived molecules to pattern-recognition receptors, such as TLRs, on the surface of immature DCs at the site of infection, the DCs mature and migrate to the lymph nodes, where they present antigen to naive T cells. The differentiation of naive T cells to T H 1 cells is promoted by the production of IL-12, IL-23 and IL-27, whereas differentiation to T H 2 cells is promoted by IL-4 and IL-6. Although there is some evidence that immature DCs can selectively activate regulatory T cells 95 , it seems that T cells induced by immature DCs are anergic rather than regulatory and that the DCs that direct the induction of regulatory T cells have an intermediate phenotype, including increased expression of MHC class II These findings indicate that, in some cases, virus-specific regulatory T cells not only prevent pathogen elimination but also can promote a generalized state of immune suppression in vivo such that the host is more susceptible to secondary infections with other pathogens or has reduced resistance to tumours.
Bacteria.
A proportion of individuals who are infected with M. tuberculosis do not have positive skin-test responses to mycobacterial purified protein derivative (PPD), and this absence of delayed-type hypersensitivity responses to mycobacterial antigens is associated with a poorer clinical outcome. T cells from patients with positive PPD skin tests proliferated and secreted IFN-γ and IL-10 in response to PPD, whereas T cells from non-responding patients produced IL-10 but not IFN-γ 25, 51 . Furthermore, IL-10-specific antibodies increased PPD-specific IFN-γ production by T cells from non-responding patients 25 . This indicates that T R 1 cells that suppress T H 1-cell responses to PPD through IL-10 production mediate T-cell suppression in patients with tuberculosis. In addition, recent studies using mice transgenic for the gene encoding IL-10 show that reactivation of chronic M. tuberculosis infection and suppression of protective T H 1-cell responses is strongly influenced by the expression of IL-10 during the latent phase of infection 85 . Furthermore, cell-mediated immunity to Mycobacterium bovis bacillus CalmetteGuérin (BCG) is increased in IL-10-deficient mice and these mice eliminate the bacteria faster than wildtype mice 86 . Collectively, these findings indicate that IL-10-producing cells, probably T R 1 cells as well as innate immune cells, contribute to the chronic state of mycobacterial infections.
Similarly, during infection with Yersinia enterocolitica, the V antigen of this pathogen stimulates IL-10 production by macrophages, which suppresses production of the host-protective cytokine TNF, and IL-10-deficient mice are highly resistant to infection with Y. enterocolitica 87 . Although Y. enterocolitica-specific regulatory T cells have not yet been documented, it is probable that the bacteriatriggered IL-10 production by macrophages facilitates suppression of protective immunity either directly or indirectly through the induction of regulatory T cells. This conclusion is supported by studies with B. pertussis, in which two bacterial virulence factors -filamentous haemagglutinin (FHA) and adenylate cyclase toxin (CyaA), which stimulate IL-10 production by macrophages and DCs -direct the induction of T R 1 cells in vivo 28, 88 . Suppression of local T H 1-cell responses early in infection with B. pertussis 89 seems to result from the induction of regulatory T cells, which can be detected in the lung during acute infection 28 , even before the appearance of T H 1 cells (P. McGuirk and K.H.G.M., unpublished observations). Furthermore, co-transfer of B. pertussis-specific T R 1-cell clones with T H 1 cells from convalescent mice to naive mice before infection with B. pertussis suppressed T H 1-cell responses and exacerbated infection 28 . Therefore, it seems that the persistence of infection with certain bacteria might be associated with the induction of IL-10-producing CD4 + T R 1 cells
Pathogen molecules that inhibit IL-12 production and increase IL-10 production have been shown to promote the induction of T R 1 cells in vitro and in vivo 8 . FHA from B. pertussis induces IL-10 production and inhibits IL-12 production by DCs and macrophages, and FHA-stimulated DCs promote the clonal expansion of IL-10-secreting T cells from naive T cells in vitro 28 . Furthermore, incubation of FHA-stimulated DCs with an IL-10-specific antibody prevents the induction of T R 1 cells, which indicates that IL-10 is a differentiation factor for T R 1 cells. Cholera toxin and B. pertussis CyaA also inhibit IL-12 production and CD40 expression by DCs and synergize with TLR ligands in activating IL-10 production by DCs and macrophages 32, 88 . DCs activated by these pathogen-derived molecules induce T R 1 and T H 2 cells. molecules and CD86 but low levels of expression of CD40 and intercellular adhesion molecule 1 (ICAM1) 32, 88, 96 . This is supported by studies showing that DCs lacking surface expression of CD40 can suppress a primed immune response and induce IL-10-secreting CD4 + regulatory T cells 96 . Furthermore, the interaction between ICAM1 and leukocyte functionassociated antigen 1 (LFA1) is thought to promote the induction of T H 1 cells independently of IL-12. So, DCs in which CD40 and ICAM1 expression is suppressed but CD80 and CD86 expression is increased might promote the induction of T R 1 cells but block the differentiation of T H 1 cells 8 . The cytokine environment that promotes the differentiation of regulatory T cells is also distinct from that which drives T H 1-and T H 2-cell differentiation. These studies have also helped to increase our understanding of the role of regulatory T cells in immune homeostasis and how they could be manipulated for the treatment of human diseases. In a normal healthy individual, the immune system must be capable of preventing the development of autoimmune diseases by suppressing immune responses to self-antigens. It must also be able to mount immune responses that control infections with a range of pathogenic organisms. Immune homeostasis is achieved through a careful balance between effector and suppressor responses, possibly through an appropriate frequency of T H 1 cells, T H 2 cells and CTLs versus natural and induced regulatory T cells (FIG. 5) . The development of autoimmunity and allergy might, in part, arise from a deficit in regulatory T cells, whereas the development of cancer and chronic infections might be associated with an excess of these cells. Therefore, manipulation of this balance has opened up new approaches to therapy for a range of human diseases.
The clonal expansion of regulatory T cells using strategies traditionally associated with the induction of tolerance has had some success in reducing symptoms of autoimmune disease in animal models 26, 101 . However, this approach requires further development before it can be routinely applied to humans. Studies of animal tumour models have shown that altering the ratio of regulatory T cells to T H 1 cells and CTLs can affect tumour survival; removal of CD4 + CD25
+ T cells increases anti-tumour immunity 102 , and therapy with pathogen-derived molecules that promote T H 1-cell and CTL responses versus T R 1-cell responses results in reduced versus increased tumour survival, respectively (A. Jarnicki, J. Lysaght, S. Todryk and K.H.G.M., unpublished observations). In mouse models of infectious disease, there is some evidence that removal of CD4 + CD25
+ regulatory T cells can help to resolve infection 36, 91 . However, the application of this approach to humans will not be straightforward or without risk, and there are many unanswered questions. Will it be possible to deplete CD4 + T Reg cells be sufficient for resolution of infection and, if not, will the longer-term removal of these cells increase the risk of developing autoimmunity? Inhibition of pathogen-induced T R 1 or T H 3 cells or the cytokines they secrete is an alternative approach for the treatment of chronic infections. Studies with PBMCs from patients infected with HCV 60 or with M. tuberculosis 25 have shown that antigen-specific IFN-γ secretion can be increased in vitro by the addition of IL-10-specific antibodies. Targeting IL-10 and TGF-β has the advantage of inhibiting the innate cytokines that induce regulatory T cells, as well as the products of these cells that mediate suppression. However, this is also not without risk because antiinflammatory cytokines can favour T cells that mediate pathogen clearance, but if uncontrolled, the same T cells can contribute to immunopathology. Therefore, the key to success with immunotherapeutic approaches will be to elicit the correct balance of effector/pathogenic and regulatory T cells.
Lactobacillus paracasei inhibits the proliferation of and the T H 1 and T H 2 cytokine production by ALLOREACTIVE T cells, but it increases IL-10 and TGF-β production, indicating that these bacteria probably promote the induction of regulatory T cells 97 . C. albicans hyphae induce IL-4 and IL-10 production by DCs, and hyphaepulsed DCs can induce the clonal expansion of CD4 + CD25 + T cells in vivo. Furthermore, an antibody specific for the IL-10R prevented the clonal expansion of CD4 + CD25 + T cells in C. albicans-infected mice 70 . It seems, however, that the source of innate IL-10 that promotes the induction of T R 1 cells is not confined to DCs. Non-structural protein 4 from HCV stimulates IL-10 production by monocytes (but not DCs), which in turn activates DCs to induce T R 1 cells at the expense of T H 1 cells 60 . EBV infection is associated with the induction of T R 1-type cells specific for LMP1. EBV produces a viral homologue of mammalian IL-10, which is expressed, together with LMP1, during the lytic cycle. Because LMP1-specific IL-10-secreting T cells are induced in EBV-infected individuals, viral IL-10 might help to promote the differentiation of these T R 1 cells in vivo 50 . Therefore, the production of immunoregulatory cytokines -IL-10 and TGF-β, and possibly IFN-α -by innate immune cells in response to certain pathogenderived products, together with the suppression of IL-12 production and the selective activation of co-stimulatory molecule expression by DCs, might have an important influence on the induction of regulatory T cells during infection. Finally, it has also been proposed that regulatory T cells might respond directly to physiological or pathogenic ligand interaction with TLR4 (REF. 98) or CD46 (REF. 99) expressed on the surface of T cells.
Conclusions and therapeutic prospects
The study of regulatory T cells in the context of infection has shown that these cells form an essential component of the protective armoury of the host immune system through their ability to limit immunopathology and allow the development of immunological memory. However, regulatory T cells can also be detrimental to the host because they can be exploited by pathogens to facilitate pathogen persistence by suppressing anti-pathogen protective immune responses. This review has provided evidence from many studies that regulatory T cells can be both beneficial and detrimental to the host in response to the same pathogen. An explanation for these apparently contradictory findings might lie in the balance between regulatory and effector cells in different individuals, disease settings and experimental systems. The different outcomes of infection -persistence, resolution with excessive collateral damage, or resolution with limited immunopathology and development of immune memory -might be influenced by the ratio of regulatory T cells to effector T cells (FIG. 5) . This hypothesis is supported by a recent report showing that re-infection of mice with L. major at a secondary site increased the number of regulatory T cells, resulting in disease reactivation at the primary site of infection; the equilibrium between effector and regulatory T cells controlled the efficiency of recall immune responses and disease reactivation 100 .
ALLOREACTIVE
Responding to antigens that are distinct between members of the same species, such as MHC molecules or blood-group antigens.
